Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number of leukemias and lym

---

Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number of leukemias and lymphomas. Generic name and stylized antibody representation.

---

Size: 6058px × 2602px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: -cell, -hodgkin, -lymphocyte, antibody, antigen, arthritis, autoimmune, biological, biosimilar, biotech, biotechnology, blood, cancer, cd20, cell, chronic, disease, drug, idiopathic, immunoglobulin, immunology, infusion, injection, inn, leukemia, lupus, lymphocytic, lymphoma, mab, malignant, monoclonal, multiple, nomenclature, pemphigus, peptide, protein, purpura, rheumatoid, rituximab, sclerosis, thrombocytopenic, transplant, vulgaris, white